glp-1 agonist in esrd Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials Recommendations for SGLT2i versus GLP-1

L.ShenJ.NicolettiP.ShenY.et al (2015)

What began as a diabetes treatment story has rapidly evolved into a broader metabolic health transformation

This led to the consideration of GLP-1RA as medications that could change cell function and survival in patients with T1D

Abukhalil, Al-Hussein Bin Talal University, Jordan

Burns says he asks every new patient with type 2 diabetes: "Has anyone ever told you this is reversible?" He says, Invariably, they say no. But type 2 diabetes can be reversed through diet

In the clinical experience of the authors, such effects tend to be variable in terms of severity and usually resolve with continuous use